Mometasone Topical: MedlinePlus Drug Information.
Looking for:
Mometasone furoate cream usp 0.1 directions |
Mometasone for skin – steroid creams used to treat eczema and psoriasis - NHS
The following tests may be helpful in evaluating patients for HPA axis suppression:. Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Long-term carcinogenicity studies of mometasone furoate were conducted by the inhalation route in rats and mice. Mometasone furoate increased chromosomal aberrations in an in vitro Chinese hamster ovary cell assay, but did not increase chromosomal aberrations in an in vitro Chinese hamster lung cell assay.
Mometasone furoate was not mutagenic in the Ames test or mouse lymphoma assay, and was not clastogenic in an in vivo mouse micronucleus assay, a rat bone marrow chromosomal aberration assay, or a mouse male germ-cell chromosomal aberration assay.
Mometasone furoate also did not induce unscheduled DNA synthesis in vivo in rat hepatocytes. Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels.
Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. When administered to pregnant rats, rabbits, and mice, mometasone furoate increased fetal malformations. Mometasone furoate also caused dystocia and related complications when administered to rats during the end of pregnancy.
Similar effects were not observed at 7. Doses of 7. There are no adequate and well-controlled studies of teratogenic effects from topically applied corticosteroids in pregnant women. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Because many drugs are excreted in human milk, caution should be exercised when mometasone furoate cream USP 0. Use of mometasone furoate cream USP 0. Follow-up testing 2 to 4 weeks after study completion, available for 5 of the patients, demonstrated suppressed HPA axis function in one patient, using these same criteria.
Pediatric patients may be more susceptible than adults to skin atrophy, including striae, when they are treated with topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and an absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. Clinical studies of mometasone furoate cream USP 0. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients.
However, greater sensitivity of some older individuals cannot be ruled out. In controlled clinical studies involving patients, the incidence of adverse reactions associated with the use of mometasone furoate cream USP 0.
Reported reactions included burning, pruritus, and skin atrophy. Reports of rosacea associated with the use of mometasone furoate cream USP 0. Reported reactions included stinging, pruritus, and furunculosis. The following adverse reactions were reported to be possibly or probably related to treatment with mometasone furoate cream USP 0. The following signs of skin atrophy were also observed among 97 patients treated with mometasone furoate cream USP 0.
Mometasone topical is used to relieve the redness, swelling, itching and inflammation and discomfort of various skin conditions, including psoriasis a skin disease in which red, scaly patches form on some areas of the body and eczema a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes.
Mometasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Mometasone comes as a cream, ointment, and lotion for use on the skin. It usually is applied once a day. Apply it at around the same time every day.
Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use mometasone exactly as directed. Do not apply more or less of it or apply it more often than prescribed by your doctor.
Do not apply it to other areas of your body or use it to treat other skin conditions unless directed to do so by your doctor. Your skin condition should improve during the first 2 weeks of your treatment.
Call your doctor if your symptoms do not improve during this time. To use mometasone cream or ointment, apply a small amount of cream or ointment to cover the affected area of skin with a thin film.
To apply the lotion, place a few drops on the affected areas and massage lightly until it disappears. This medication is only for use on the skin. Do not let mometasone topical get into your eyes or mouth and do not swallow it. Avoid use on the face, in the genital and rectal areas, and in skin creases and armpits unless directed by your doctor. Do not wrap or bandage the treated area unless your doctor tells you that you should. Such use may increase side effects. Do not use on a child's diaper area unless your doctor tells you that you should; do not use tight-fitting diapers or plastic pants.
There is a problem with information submitted for this request. Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID, plus expertise on managing health. To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you.
If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail. You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Mayo Clinic does not endorse companies or products.
Advertising revenue supports our not-for-profit mission. Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.
This site complies with the HONcode standard for trustworthy health information: verify here. This content does not have an English version.
❿- Mometasone (Topical Application Route) Proper Use - Mayo Clinic
Mometasone furoate cream usp 0.1 directions
Talk to your doctor if you're worried. They will be able to explain the benefits and risks of your child using mometasone. It happens rarely but it is possible to have a serious allergic reaction anaphylaxis to mometasone. These are not all the side effects of mometasone. For a full list see the leaflet inside your medicines packet. Mometasone skin treatments are not normally recommended if you're pregnant.
Only use mometasone if your doctor or dermatologist skin specialist prescribes it and is supervising your treatment. They will be able to explain the benefits and risks of using mometasone. If you're using mometasone on your breasts, wash off any cream or ointment from your breasts, then wash your hands before feeding your baby. It's usually better to use cream rather than ointment when breastfeeding, as it's easier to wash off.
For more information about how mometasone for skin might affect you and your baby during pregnancy, read this leaflet about steroid creams and ointments on the Best Use of Medicines in Pregnancy BUMPs website.
Other medicines are unlikely to affect the way mometasone skin treatments work. There's very little information about taking herbal remedies and supplements while using mometasone. Ask a pharmacist for advice. Tell your doctor or pharmacist if you're taking any other medicines, including herbal medicines, vitamins or supplements.
Mometasone is a steroid also called a corticosteroid. Steroids help to reduce swelling inflammation in the skin and other parts of the body. Skin gets inflamed when an allergic reaction or irritation causes chemicals to be released in the skin. These make your blood vessels widen and your irritated skin becomes red, swollen, itchy and painful. This reduces any swelling, redness and itching. Speak to your doctor if there if your skin does not get better after 14 days, or if your skin gets worse at any time.
For long-term skin problems, such as eczema and psoriasis, you may need to use mometasone for 1 or 2 weeks, or sometimes for longer. Do not use mometasone on your face for more than 5 days, unless your doctor tells you this is OK.
If your symptoms get worse or if they have not improved after 14 days after 5 days for a child , ask your doctor for further advice. Once your skin is better, you can use an emollient moisturising treatment to keep it from becoming inflamed again.
If you need treatment for a long time, your doctor may decide you need to use a milder cream or ointment. Talk to your doctor before stopping treatment if you've been using mometasone for a long time.
They may tell you to gradually use less of it, and use it less often, before you stop completely. This reduces the chance of your symptoms coming back. Using mometasone for a long time without stopping can mean some of the medicine gets into your bloodstream.
If you have been using mometasone for a long time, your doctor may tell you to gradually reduce the amount you use, or use a milder steroid, before stopping completely. The skin on your face is delicate. If a doctor has said you can use it on your face, do not use it for more than 5 days. Steroids like mometasone reduce swelling inflammation in your skin to help manage your symptoms.
They do not cure eczema. If you feel your symptoms are getting worse after using mometasone, it's important to tell a doctor. When you stop using mometasone, skin conditions like eczema and psoriasis can flare up again. You can avoid this by gradually reducing the amount you put on, and how often you use it.
Since safety and efficacy of mometasone furoate cream USP 0. Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal HPA axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression.
If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid. Recovery of HPA axis function is generally prompt upon discontinuation of topical corticosteroids.
Infrequently, signs and symptoms of glucocorticosteroid insufficiency may occur requiring supplemental systemic corticosteroids. For information on systemic supplementation, see Prescribing Information for those products. If irritation develops, mometasone furoate cream USP 0. Allergic contact dermatitis with corticosteroids is usually diagnosed by observing a failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids.
Such an observation should be corroborated with appropriate diagnostic patch testing. If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of mometasone furoate cream USP 0. Patients using topical corticosteroids should receive the following information and instructions:. The following tests may be helpful in evaluating patients for HPA axis suppression:.
Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Long-term carcinogenicity studies of mometasone furoate were conducted by the inhalation route in rats and mice. Mometasone furoate increased chromosomal aberrations in an in vitro Chinese hamster ovary cell assay, but did not increase chromosomal aberrations in an in vitro Chinese hamster lung cell assay.
Mometasone furoate was not mutagenic in the Ames test or mouse lymphoma assay, and was not clastogenic in an in vivo mouse micronucleus assay, a rat bone marrow chromosomal aberration assay, or a mouse male germ-cell chromosomal aberration assay.
Mometasone furoate also did not induce unscheduled DNA synthesis in vivo in rat hepatocytes. Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels.
Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. When administered to pregnant rats, rabbits, and mice, mometasone furoate increased fetal malformations. Mometasone furoate also caused dystocia and related complications when administered to rats during the end of pregnancy. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered.
To do so may cause unwanted side effects or skin irritation. This medicine is for use on the skin only. Do not get it into your eyes. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water. This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present.
This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns. Do not use this medicine on the face, groin, or underarms unless directed to do so by your doctor. Do not use this medicine in the diaper area of an infant. Mometasone topical is used to relieve the redness, swelling, itching and inflammation and discomfort of various skin conditions, including psoriasis a skin disease in which red, scaly patches form on some areas of the body and eczema a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes.
Mometasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Mometasone comes as a cream, ointment, and lotion for use on the skin. It usually is applied once a day. Apply it at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use mometasone exactly as directed.
Do not apply more or less of it or apply it more often than prescribed by your doctor. Do not apply it to other areas of your body or use it to treat other skin conditions unless directed to do so by your doctor. Your skin condition should improve during the first 2 weeks of your treatment. Call your doctor if your symptoms do not improve during this time. To use mometasone cream or ointment, apply a small amount of cream or ointment to cover the affected area of skin with a thin film.
To apply the lotion, place a few drops on the affected areas and massage lightly until it disappears. This medication is only for use on the skin.
Mometasone furoate cream USP 0. Mometasone furoate is a synthetic corticosteroid with anti-inflammatory activity. Mometasone furoate is a white to off-white powder practically insoluble in water, slightly soluble in octanol, and moderately soluble in ethyl alcohol. Each gram of mometasone furoate cream USP 0. Like other topical corticosteroids, mometasone furoate has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear.
However, corticosteroids are thought to act by the induction of phospholipase A 2 inhibitory proteins, collectively called lipocortins.
It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
Arachidonic acid is released from membrane phospholipids by phospholipase A 2. The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier. Occlusive dressings with hydrocortisone for up to 24 hours have not been demonstrated to increase penetration; however, occlusion of hydrocortisone for 96 hours markedly enhances penetration. Studies in humans indicate that approximately 0.
Studies performed with mometasone furoate cream USP 0. In a study evaluating the effects of mometasone furoate cream on the hypothalamic-pituitary-adrenal HPA axis, 15 grams were applied twice daily for 7 days to six adult patients with psoriasis or atopic dermatitis.
The results show that the drug caused a slight lowering of adrenal corticosteroid secretion. In a pediatric trial, 24 atopic dermatitis patients, of which 19 patients were age 2 to 12 years, were treated with mometasone furoate cream USP 0.
The majority of patients cleared within 3 weeks. Ninety-seven pediatric patients ages 6 to 23 months, with atopic dermatitis, were enrolled in an open-label, hypothalamic-pituitary-adrenal HPA axis safety study. Follow-up testing 2 to 4 weeks after stopping treatment, available for 5 of the patients, demonstrated suppressed HPA axis function in one patient, using these same criteria.
Since safety and efficacy of mometasone furoate cream USP 0. Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal HPA axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment.
Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid.
Recovery of HPA axis function is generally prompt upon discontinuation of topical corticosteroids. Infrequently, signs and symptoms of glucocorticosteroid insufficiency may occur requiring supplemental systemic corticosteroids.
For information on systemic supplementation, see Prescribing Information for those products. If irritation develops, mometasone furoate cream USP 0. Allergic contact dermatitis with corticosteroids is usually diagnosed by observing a failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids.
Such an observation should be corroborated with appropriate diagnostic patch testing. If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used.
If a favorable response does not occur promptly, use of mometasone furoate cream USP 0. Patients using topical corticosteroids should receive the following information and instructions:.
The following tests may be helpful in evaluating patients for HPA axis suppression:. Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Long-term carcinogenicity studies of mometasone furoate were conducted by the inhalation route in rats and mice. Mometasone furoate increased chromosomal aberrations in an in vitro Chinese hamster ovary cell assay, but did not increase chromosomal aberrations in an in vitro Chinese hamster lung cell assay.
Mometasone furoate was not mutagenic in the Ames test or mouse lymphoma assay, and was not clastogenic in an in vivo mouse micronucleus assay, a rat bone marrow chromosomal aberration assay, or a mouse male germ-cell chromosomal aberration assay. Mometasone furoate also did not induce unscheduled DNA synthesis in vivo in rat hepatocytes. Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels.
Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. When administered to pregnant rats, rabbits, and mice, mometasone furoate increased fetal malformations. Mometasone furoate also caused dystocia and related complications when administered to rats during the end of pregnancy.
Similar effects were not observed at 7. Doses of 7. There are no adequate and well-controlled studies of teratogenic effects from topically applied corticosteroids in pregnant women. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Because many drugs are excreted in human milk, caution should be exercised when mometasone furoate cream USP 0. Use of mometasone furoate cream USP 0. Follow-up testing 2 to 4 weeks after study completion, available for 5 of the patients, demonstrated suppressed HPA axis function in one patient, using these same criteria.
Pediatric patients may be more susceptible than adults to skin atrophy, including striae, when they are treated with topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and an absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. Clinical studies of mometasone furoate cream USP 0.
No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients.
However, greater sensitivity of some older individuals cannot be ruled out. In controlled clinical studies involving patients, the incidence of adverse reactions associated with the use of mometasone furoate cream USP 0. Reported reactions included burning, pruritus, and skin atrophy. Reports of rosacea associated with the use of mometasone furoate cream USP 0. Reported reactions included stinging, pruritus, and furunculosis. The following adverse reactions were reported to be possibly or probably related to treatment with mometasone furoate cream USP 0.
The following signs of skin atrophy were also observed among 97 patients treated with mometasone furoate cream USP 0. Striae were not observed in this study. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, and miliaria.
Topically applied mometasone furoate cream USP 0. Apply a thin film of mometasone furoate cream USP 0. As with other corticosteroids, therapy should be discontinued when control is achieved.
If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP 0. Glenmark Generics Ltd. Tulsa, OK Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier.
Information for Patients: Patients using topical corticosteroids should receive the following information and instructions: This medication is to be used as directed by the physician.
It is for external use only. Avoid contact with the eyes. This medication should not be used for any disorder other than that for which it was prescribed. The treated skin area should not be bandaged or otherwise covered or wrapped so as to be occlusive, unless directed by the physician.
Patients should report to their physician any signs of local adverse reactions. Parents of pediatric patients should be advised not to use mometasone furoate cream USP 0. This medication should not be used on the face, underarms, or groin areas unless directed by the physician.
If no improvement is seen within 2 weeks, contact the physician. Other corticosteroid-containing products should not be used with mometasone furoate cream USP 0. Carcinogenesis, Mutagenesis, Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Pregnancy: Teratogenic Effects: Pregnancy Category C: Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels.
Nursing Mothers: Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Manufactured: Glenmark Generics Ltd. Principal Display Panel. Product Information. Inactive Ingredients.
Marketing Information. Labeler - Physicians Total Care, Inc.
localhost › Professionals › FDA PI › Mometasone Cream. This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Mometasone decreases swelling (inflammation), itching. 1 g of cream contains 1 mg of mometasone furoate (% w/w mometasone furoate). Excipients with known effect: 70 mg propylene glycol monopalmitostearate per. Mometasone Furoate % w/w Cream is indicated for the treatment of inflammatory pruritic manifestations of and psoriasis (excluding widespread plaque. DOSAGE AND ADMINISTRATION. Apply a thin film of mometasone furoate cream USP % to the affected skin areas once daily. Mometasone furoate cream USP % may. If someone swallows mometasone topical, call your local poison control center atMometasone topical is used to relieve the redness, swelling, itching and inflammation and discomfort of various skin conditions, including psoriasis a skin disease in which red, scaly patches form on some areas of the body and eczema a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes.
Mometasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Mometasone comes as a cream, ointment, and lotion for use on the skin. It usually is applied once a day. Apply it at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use mometasone exactly as directed.
Do not apply more or less of it or apply it more often than prescribed by your doctor. Do not apply it to other areas of your body or use it to treat other skin conditions unless directed to do so by your doctor. Your skin condition should improve during the first 2 weeks of your treatment. Call your doctor if your symptoms do not improve during this time. To use mometasone cream or ointment, apply a small amount of cream or ointment to cover the affected area of skin with a thin film.
To apply the lotion, place a few drops on the affected areas and massage lightly until it disappears. This medication is only for use on the skin.
Do not let mometasone topical get into your eyes or mouth and do not swallow it. Avoid use on the face, in the genital and rectal areas, and in skin creases and armpits unless directed by your doctor. Do not wrap or bandage the treated area unless your doctor tells you that you should. Such use may increase side effects.
Do not use on a child's diaper area unless your doctor tells you that you should; do not use tight-fitting diapers or plastic pants. This medication may be prescribed for other uses; ask your doctor or pharmacist for more information. Apply the missed dose as soon as you remember it, However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule.
Do not apply a double amount to make up for a missed dose. Children who use mometasone topical may have an increased risk of side effects including slowed growth and delayed weight gain.
Talk to your child's doctor about the risks of applying this medication to your child's skin. Mometasone topical may cause other side effects. Call your doctor if you have any unusual problems while using this medication. Keep this medication in the container it came in, tightly closed, and out of reach of children.
Store it at room temperature and away from excess heat and moisture not in the bathroom. Do not freeze it. It is important to keep all medication out of sight and reach of children as many containers such as weekly pill minders and those for eye drops, creams, patches, and inhalers are not child-resistant and young children can open them easily.
To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location — one that is up and away and out of their sight and reach. If someone swallows mometasone topical, call your local poison control center at If the victim has collapsed or is not breathing, call local emergency services at Do not let anyone else use your medication.
Ask your pharmacist any questions you have about refilling your prescription. It is important for you to keep a written list of all of the prescription and nonprescription over-the-counter medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements.
You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Generic alternatives may be available. Mometasone Topical pronounced as moe met' a sone. Why is this medication prescribed?
How should this medicine be used? Other uses for this medicine What special precautions should I follow? What should I do if I forget a dose? What side effects can this medication cause?
What should I know about storage and disposal of this medication? Brand names. Do not apply other skin preparations on the treated area without talking with your doctor. Other uses for this medicine. What special precautions should I follow?
Before using mometasone, tell your doctor and pharmacist if you are allergic to mometasone, any other medications, or any of the ingredients in mometasone topical products. Ask your pharmacist for a list of the ingredients. Be sure to mention the following: other corticosteroid medications and other topical medications. If you become pregnant while using mometasone topical, call your doctor.
Mometasone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: burning, itching, irritation, redness, or dryness of the skin acne skin sores tiny red bumps or rash around the mouth small white or red bumps on the skin bruising or shiny skin changes in skin color If you experience any of the following symptoms, call your doctor immediately: severe skin rash redness, swelling, or other signs of skin infection in the place where you applied mometasone Children who use mometasone topical may have an increased risk of side effects including slowed growth and delayed weight gain.
What other information should I know? Keep all appointments with your doctor. Browse Drugs and Medicines.
Comments
Post a Comment